Control of breast cancer patient-derived xenografts by CD70-targeted HIT-CAR T cells.

Lindenbergh PL, Rajasekhar VK, Linkov I, Mansilla-Soto J, Hanina SA, Sadelain M

Open source

DOI
10.3389/fimmu.2026.1852493
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1852493,
  title = {Control of breast cancer patient-derived xenografts by CD70-targeted HIT-CAR T cells.},
  author = {Lindenbergh PL and Rajasekhar VK and Linkov I and Mansilla-Soto J and Hanina SA and Sadelain M},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1852493},
  url = {https://doi.org/10.3389/fimmu.2026.1852493}
}

RIS

TY  - JOUR
TI  - Control of breast cancer patient-derived xenografts by CD70-targeted HIT-CAR T cells.
AU  - Lindenbergh PL
AU  - Rajasekhar VK
AU  - Linkov I
AU  - Mansilla-Soto J
AU  - Hanina SA
AU  - Sadelain M
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1852493
UR  - https://doi.org/10.3389/fimmu.2026.1852493
ER  - 

APA

PL, L., VK, R., I, L., J, M., SA, H., & M, S. (2026). Control of breast cancer patient-derived xenografts by CD70-targeted HIT-CAR T cells.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1852493

Source records